Trials / Completed
CompletedNCT04921176
Evaluating Quality of Life of AF Patients Following a Bleed
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Swansea University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
EQUAL-AF is an observational feasibility study which will determine if there is a long-term effect of bleeding for patients diagnosed with AF, who are taking anticoagulants. The investigators will use three validated questionnaires/PROMs (AFEQT, EQ5D-3L, and PACT-Q) to gather data from a patient perspective. Patients will complete all questionnaires no more than 4 weeks following a bleed and a second time 3 months later. As this study tests feasibility, progression criteria will apply. The primary objective is to assess recruitment success to ensure that the patient population is accessible and willing to engage with the research team. Additionally, the investigators will look to identify the need for a specific bleeding PROM which will assess long-term quality of life impact for patients experiencing bleeds while anticoagulated.
Conditions
Timeline
- Start date
- 2020-12-22
- Primary completion
- 2022-03-09
- Completion
- 2022-03-09
- First posted
- 2021-06-10
- Last updated
- 2023-04-28
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04921176. Inclusion in this directory is not an endorsement.